Valneva COVID jab set to have over 80% efficacy
Valneva President Franck Grimaud said on Tuesday he believes the company’s COVID-19 vaccine could prove to have an efficacy of over 80% during its late-stage trials.
“Based on … phase I an…
Valneva President Franck Grimaud said on Tuesday he believes the company’s COVID-19 vaccine could prove to have an efficacy of over 80% during its late-stage trials.
“Based on … phase I an…